Reply: Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy.

REPLY: Dr. Wee and colleagues reviewed their database of gastroenteropancreatic neuroendocrine tumor patients treated with 177Lu-DOTATATE and observed patterns of bowel obstruction very similar to those described in our study ( [1][1] ). These corroborating data significantly strengthen the evidence